APO Research
Talk to an analyst

APO RESEARCH · REPORT

Skeletal Muscle Relaxants

Compare research editions
View pricing & licenses

Selected research

Industry Research

Skeletal Muscle Relaxants Industry Research Report 2026

20 December 2025138 pages

Choose your research edition.

Industry ResearchSkeletal Muscle Relaxants Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Skeletal Muscle Relaxants Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Skeletal Muscle Relaxants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Skeletal Muscle Relaxants Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Skeletal Muscle Relaxants Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Skeletal Muscle Relaxants market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Skeletal Muscle Relaxants is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Skeletal Muscle Relaxants is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Skeletal Muscle Relaxants is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Skeletal Muscle Relaxants include Teva Pharmaceutical Industries, Novartis, Merck, Mylan, Pfizer, Fresenius Kabi India, Teijin, Sandoz International and Par Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Skeletal Muscle Relaxants market in terms of revenue (US$ million) and, where applicable, sales volume (L), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/L) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Skeletal Muscle Relaxants Market by Company

Teva Pharmaceutical Industries

Novartis

Merck

Mylan

Pfizer

Fresenius Kabi India

Teijin

Sandoz International

Par Pharmaceutical

Orient Pharma

Ipsen

Hikma Pharmaceuticals

Aurobindo Pharma

Amneal Pharmaceuticals

Accord Healthcare

Skeletal Muscle Relaxants Segment by Type

Depolarizing

Non-depolarizing

Skeletal Muscle Relaxants Segment by Application

Intensive Care

Surgery

Rehabilitation

Skeletal Muscle Relaxants Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Skeletal Muscle Relaxants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Skeletal Muscle Relaxants and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Skeletal Muscle Relaxants.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Skeletal Muscle Relaxants manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Skeletal Muscle Relaxants by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Skeletal Muscle Relaxants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Skeletal Muscle Relaxants Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Skeletal Muscle Relaxants Sales (L) of Manufacturers (2021-2026) Table 7. Global Skeletal Muscle Relaxants Sales Market Share by Manufacturers (2021-2026) Table 8. Global Skeletal Muscle Relaxants Revenue of Manufacturers (2021-2026) Table 9. Global Skeletal Muscle Relaxants Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Skeletal Muscle Relaxants Average Price (US$/ml) of Manufacturers (2021-2026) Table 11. Global Skeletal Muscle Relaxants Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Skeletal Muscle Relaxants, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Skeletal Muscle Relaxants, Product Type & Application Table 14. Global Skeletal Muscle Relaxants Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Skeletal Muscle Relaxants by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Teva Pharmaceutical Industries Company Information Table 19. Teva Pharmaceutical Industries Business Overview Table 20. Teva Pharmaceutical Industries Skeletal Muscle Relaxants Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 21. Teva Pharmaceutical Industries Skeletal Muscle Relaxants Product Portfolio Table 22. Teva Pharmaceutical Industries Recent Developments Table 23. Novartis Company Information Table 24. Novartis Business Overview Table 25. Novartis Skeletal Muscle Relaxants Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 26. Novartis Skeletal Muscle Relaxants Product Portfolio Table 27. Novartis Recent Developments Table 28. Merck Company Information Table 29. Merck Business Overview Table 30. Merck Skeletal Muscle Relaxants Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 31. Merck Skeletal Muscle Relaxants Product Portfolio Table 32. Merck Recent Developments Table 33. Mylan Company Information Table 34. Mylan Business Overview Table 35. Mylan Skeletal Muscle Relaxants Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 36. Mylan Skeletal Muscle Relaxants Product Portfolio Table 37. Mylan Recent Developments Table 38. Pfizer Company Information Table 39. Pfizer Business Overview Table 40. Pfizer Skeletal Muscle Relaxants Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 41. Pfizer Skeletal Muscle Relaxants Product Portfolio Table 42. Pfizer Recent Developments Table 43. Fresenius Kabi India Company Information Table 44. Fresenius Kabi India Business Overview Table 45. Fresenius Kabi India Skeletal Muscle Relaxants Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 46. Fresenius Kabi India Skeletal Muscle Relaxants Product Portfolio Table 47. Fresenius Kabi India Recent Developments Table 48. Teijin Company Information Table 49. Teijin Business Overview Table 50. Teijin Skeletal Muscle Relaxants Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 51. Teijin Skeletal Muscle Relaxants Product Portfolio Table 52. Teijin Recent Developments Table 53. Sandoz International Company Information Table 54. Sandoz International Business Overview Table 55. Sandoz International Skeletal Muscle Relaxants Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 56. Sandoz International Skeletal Muscle Relaxants Product Portfolio Table 57. Sandoz International Recent Developments Table 58. Par Pharmaceutical Company Information Table 59. Par Pharmaceutical Business Overview Table 60. Par Pharmaceutical Skeletal Muscle Relaxants Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 61. Par Pharmaceutical Skeletal Muscle Relaxants Product Portfolio Table 62. Par Pharmaceutical Recent Developments Table 63. Orient Pharma Company Information Table 64. Orient Pharma Business Overview Table 65. Orient Pharma Skeletal Muscle Relaxants Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 66. Orient Pharma Skeletal Muscle Relaxants Product Portfolio Table 67. Orient Pharma Recent Developments Table 68. Ipsen Company Information Table 69. Ipsen Business Overview Table 70. Ipsen Skeletal Muscle Relaxants Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 71. Ipsen Skeletal Muscle Relaxants Product Portfolio Table 72. Ipsen Recent Developments Table 73. Hikma Pharmaceuticals Company Information Table 74. Hikma Pharmaceuticals Business Overview Table 75. Hikma Pharmaceuticals Skeletal Muscle Relaxants Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 76. Hikma Pharmaceuticals Skeletal Muscle Relaxants Product Portfolio Table 77. Hikma Pharmaceuticals Recent Developments Table 78. Aurobindo Pharma Company Information Table 79. Aurobindo Pharma Business Overview Table 80. Aurobindo Pharma Skeletal Muscle Relaxants Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 81. Aurobindo Pharma Skeletal Muscle Relaxants Product Portfolio Table 82. Aurobindo Pharma Recent Developments Table 83. Amneal Pharmaceuticals Company Information Table 84. Amneal Pharmaceuticals Business Overview Table 85. Amneal Pharmaceuticals Skeletal Muscle Relaxants Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 86. Amneal Pharmaceuticals Skeletal Muscle Relaxants Product Portfolio Table 87. Amneal Pharmaceuticals Recent Developments Table 88. Accord Healthcare Company Information Table 89. Accord Healthcare Business Overview Table 90. Accord Healthcare Skeletal Muscle Relaxants Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 91. Accord Healthcare Skeletal Muscle Relaxants Product Portfolio Table 92. Accord Healthcare Recent Developments Table 93. Global Skeletal Muscle Relaxants Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 94. Global Skeletal Muscle Relaxants Sales by Region (2021-2026) & (L) Table 95. Global Skeletal Muscle Relaxants Sales Market Share by Region (2021-2026) Table 96. Global Skeletal Muscle Relaxants Sales by Region (2027-2032) & (L) Table 97. Global Skeletal Muscle Relaxants Sales Market Share by Region (2027-2032) Table 98. Global Skeletal Muscle Relaxants Revenue by Region (2021-2026) & (US$ Million) Table 99. Global Skeletal Muscle Relaxants Revenue Market Share by Region (2021-2026) Table 100. Global Skeletal Muscle Relaxants Revenue by Region (2027-2032) & (US$ Million) Table 101. Global Skeletal Muscle Relaxants Revenue Market Share by Region (2027-2032) Table 102. North America Skeletal Muscle Relaxants Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. North America Skeletal Muscle Relaxants Sales by Country (2021-2026) & (L) Table 104. North America Skeletal Muscle Relaxants Sales by Country (2027-2032) & (L) Table 105. North America Skeletal Muscle Relaxants Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Skeletal Muscle Relaxants Revenue by Country (2027-2032) & (US$ Million) Table 107. Europe Skeletal Muscle Relaxants Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Europe Skeletal Muscle Relaxants Sales by Country (2021-2026) & (L) Table 109. Europe Skeletal Muscle Relaxants Sales by Country (2027-2032) & (L) Table 110. Europe Skeletal Muscle Relaxants Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Skeletal Muscle Relaxants Revenue by Country (2027-2032) & (US$ Million) Table 112. Asia Pacific Skeletal Muscle Relaxants Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Asia Pacific Skeletal Muscle Relaxants Sales by Country (2021-2026) & (L) Table 114. Asia Pacific Skeletal Muscle Relaxants Sales by Country (2027-2032) & (L) Table 115. Asia Pacific Skeletal Muscle Relaxants Revenue by Country (2021-2026) & (US$ Million) Table 116. Asia Pacific Skeletal Muscle Relaxants Revenue by Country (2027-2032) & (US$ Million) Table 117. South America Skeletal Muscle Relaxants Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. South America Skeletal Muscle Relaxants Sales by Country (2021-2026) & (L) Table 119. South America Skeletal Muscle Relaxants Sales by Country (2027-2032) & (L) Table 120. South America Skeletal Muscle Relaxants Revenue by Country (2021-2026) & (US$ Million) Table 121. South America Skeletal Muscle Relaxants Revenue by Country (2027-2032) & (US$ Million) Table 122. Middle East and Africa Skeletal Muscle Relaxants Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Middle East and Africa Skeletal Muscle Relaxants Sales by Country (2021-2026) & (L) Table 124. Middle East and Africa Skeletal Muscle Relaxants Sales by Country (2027-2032) & (L) Table 125. Middle East and Africa Skeletal Muscle Relaxants Revenue by Country (2021-2026) & (US$ Million) Table 126. Middle East and Africa Skeletal Muscle Relaxants Revenue by Country (2027-2032) & (US$ Million) Table 127. Global Skeletal Muscle Relaxants Sales by Type (2021-2026) & (L) Table 128. Global Skeletal Muscle Relaxants Sales by Type (2027-2032) & (L) Table 129. Global Skeletal Muscle Relaxants Sales Market Share by Type (2021-2026) Table 130. Global Skeletal Muscle Relaxants Sales Market Share by Type (2027-2032) Table 131. Global Skeletal Muscle Relaxants Revenue by Type (2021-2026) & (US$ Million) Table 132. Global Skeletal Muscle Relaxants Revenue by Type (2027-2032) & (US$ Million) Table 133. Global Skeletal Muscle Relaxants Revenue Market Share by Type (2021-2026) Table 134. Global Skeletal Muscle Relaxants Revenue Market Share by Type (2027-2032) Table 135. Global Skeletal Muscle Relaxants Price by Type (2021-2026) & (US$/ml) Table 136. Global Skeletal Muscle Relaxants Price by Type (2027-2032) & (US$/ml) Table 137. Global Skeletal Muscle Relaxants Sales by Application (2021-2026) & (L) Table 138. Global Skeletal Muscle Relaxants Sales by Application (2027-2032) & (L) Table 139. Global Skeletal Muscle Relaxants Sales Market Share by Application (2021-2026) Table 140. Global Skeletal Muscle Relaxants Sales Market Share by Application (2027-2032) Table 141. Global Skeletal Muscle Relaxants Revenue by Application (2021-2026) & (US$ Million) Table 142. Global Skeletal Muscle Relaxants Revenue by Application (2027-2032) & (US$ Million) Table 143. Global Skeletal Muscle Relaxants Revenue Market Share by Application (2021-2026) Table 144. Global Skeletal Muscle Relaxants Revenue Market Share by Application (2027-2032) Table 145. Global Skeletal Muscle Relaxants Price by Application (2021-2026) & (US$/ml) Table 146. Global Skeletal Muscle Relaxants Price by Application (2027-2032) & (US$/ml) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Skeletal Muscle Relaxants Distributors List Table 150. Skeletal Muscle Relaxants Customers List Table 151. Skeletal Muscle Relaxants Industry Trends Table 152. Skeletal Muscle Relaxants Industry Drivers Table 153. Skeletal Muscle Relaxants Industry Restraints Table 154. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Skeletal Muscle Relaxants Product Image Figure 5. Global Skeletal Muscle Relaxants Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Skeletal Muscle Relaxants Market Size (2021-2032) & (US$ Million) Figure 7. Global Skeletal Muscle Relaxants Sales (2021-2032) & (L) Figure 8. Global Skeletal Muscle Relaxants Average Price (US$/ml) & (2021-2032) Figure 9. Depolarizing Product Image Figure 10. Non-depolarizing Product Image Figure 11. Intensive Care Product Image Figure 12. Surgery Product Image Figure 13. Rehabilitation Product Image Figure 14. Global Skeletal Muscle Relaxants Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Skeletal Muscle Relaxants, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Skeletal Muscle Relaxants Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Skeletal Muscle Relaxants Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Skeletal Muscle Relaxants Sales by Region in 2025 Figure 20. Global Skeletal Muscle Relaxants Revenue by Region in 2025 Figure 21. North America Skeletal Muscle Relaxants Market Size by Country in 2025 Figure 22. North America Skeletal Muscle Relaxants Sales Market Share by Country (2021-2032) Figure 23. North America Skeletal Muscle Relaxants Revenue Market Share by Country (2021-2032) Figure 24. United States Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Skeletal Muscle Relaxants Market Size by Country in 2025 Figure 28. Europe Skeletal Muscle Relaxants Sales Market Share by Country (2021-2032) Figure 29. Europe Skeletal Muscle Relaxants Revenue Market Share by Country (2021-2032) Figure 30. Germany Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Skeletal Muscle Relaxants Market Size by Country in 2025 Figure 41. Asia Pacific Skeletal Muscle Relaxants Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Skeletal Muscle Relaxants Revenue Market Share by Country (2021-2032) Figure 43. China Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Skeletal Muscle Relaxants Market Size by Country in 2025 Figure 52. South America Skeletal Muscle Relaxants Sales Market Share by Country (2021-2032) Figure 53. South America Skeletal Muscle Relaxants Revenue Market Share by Country (2021-2032) Figure 54. Brazil Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Colombia Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Skeletal Muscle Relaxants Market Size by Country in 2025 Figure 59. Middle East and Africa Skeletal Muscle Relaxants Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Skeletal Muscle Relaxants Revenue Market Share by Country (2021-2032) Figure 61. Egypt Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Skeletal Muscle Relaxants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Skeletal Muscle Relaxants Sales Market Share by Type (2021-2032) Figure 67. Global Skeletal Muscle Relaxants Revenue Market Share by Type (2021-2032) Figure 68. Global Skeletal Muscle Relaxants Price (US$/ml) by Type (2021-2032) Figure 69. Global Skeletal Muscle Relaxants Sales Market Share by Application (2021-2032) Figure 70. Global Skeletal Muscle Relaxants Revenue Market Share by Application (2021-2032) Figure 71. Global Skeletal Muscle Relaxants Price (US$/ml) by Application (2021-2032) Figure 72. Skeletal Muscle Relaxants Value Chain Figure 73. Skeletal Muscle Relaxants Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Skeletal Muscle Relaxants Industry Opportunities and Challenges

Scope & coverage.

Types
  • Depolarizing
  • Non-depolarizing
Applications
  • Intensive Care
  • Surgery
  • Rehabilitation
Companies covered
  • Teva Pharmaceutical Industries
  • Novartis
  • Merck
  • Mylan
  • Pfizer
  • Fresenius Kabi India
  • Teijin
  • Sandoz International
  • Par Pharmaceutical
  • Orient Pharma
  • Ipsen
  • Hikma Pharmaceuticals
  • Aurobindo Pharma
  • Amneal Pharmaceuticals
  • Accord Healthcare

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Skeletal Muscle Relaxants Market Size (2021-2032)
  4. 2.2.2 Global Skeletal Muscle Relaxants Sales (2021-2032)
  5. 2.2.3 Global Skeletal Muscle Relaxants Market Average Price (2021-2032)
  6. 2.3 Skeletal Muscle Relaxants by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Depolarizing
  9. 2.3.3 Non-depolarizing
  10. 2.4 Skeletal Muscle Relaxants by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Intensive Care
  13. 2.4.3 Surgery
  14. 2.4.4 Rehabilitation
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Skeletal Muscle Relaxants Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Skeletal Muscle Relaxants Sales (L) of Manufacturers (2021-2026)
  3. 3.3 Global Skeletal Muscle Relaxants Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Skeletal Muscle Relaxants Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Skeletal Muscle Relaxants Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Skeletal Muscle Relaxants, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Skeletal Muscle Relaxants, Product Type & Application
  8. 3.8 Global Manufacturers of Skeletal Muscle Relaxants, Established Date
  9. 3.9 Global Skeletal Muscle Relaxants Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Teva Pharmaceutical Industries
  2. 4.1.1 Teva Pharmaceutical Industries Company Information
  3. 4.1.2 Teva Pharmaceutical Industries Business Overview
  4. 4.1.3 Teva Pharmaceutical Industries Skeletal Muscle Relaxants Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Teva Pharmaceutical Industries Skeletal Muscle Relaxants Product Portfolio
  6. 4.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 4.2 Novartis
  8. 4.2.1 Novartis Company Information
  9. 4.2.2 Novartis Business Overview
  10. 4.2.3 Novartis Skeletal Muscle Relaxants Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Novartis Skeletal Muscle Relaxants Product Portfolio
  12. 4.2.5 Novartis Recent Developments
  13. 4.3 Merck
  14. 4.3.1 Merck Company Information
  15. 4.3.2 Merck Business Overview
  16. 4.3.3 Merck Skeletal Muscle Relaxants Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Merck Skeletal Muscle Relaxants Product Portfolio
  18. 4.3.5 Merck Recent Developments
  19. 4.4 Mylan
  20. 4.4.1 Mylan Company Information
  21. 4.4.2 Mylan Business Overview
  22. 4.4.3 Mylan Skeletal Muscle Relaxants Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Mylan Skeletal Muscle Relaxants Product Portfolio
  24. 4.4.5 Mylan Recent Developments
  25. 4.5 Pfizer
  26. 4.5.1 Pfizer Company Information
  27. 4.5.2 Pfizer Business Overview
  28. 4.5.3 Pfizer Skeletal Muscle Relaxants Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Pfizer Skeletal Muscle Relaxants Product Portfolio
  30. 4.5.5 Pfizer Recent Developments
  31. 4.6 Fresenius Kabi India
  32. 4.6.1 Fresenius Kabi India Company Information
  33. 4.6.2 Fresenius Kabi India Business Overview
  34. 4.6.3 Fresenius Kabi India Skeletal Muscle Relaxants Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Fresenius Kabi India Skeletal Muscle Relaxants Product Portfolio
  36. 4.6.5 Fresenius Kabi India Recent Developments
  37. 4.7 Teijin
  38. 4.7.1 Teijin Company Information
  39. 4.7.2 Teijin Business Overview
  40. 4.7.3 Teijin Skeletal Muscle Relaxants Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Teijin Skeletal Muscle Relaxants Product Portfolio
  42. 4.7.5 Teijin Recent Developments
  43. 4.8 Sandoz International
  44. 4.8.1 Sandoz International Company Information
  45. 4.8.2 Sandoz International Business Overview
  46. 4.8.3 Sandoz International Skeletal Muscle Relaxants Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Sandoz International Skeletal Muscle Relaxants Product Portfolio
  48. 4.8.5 Sandoz International Recent Developments
  49. 4.9 Par Pharmaceutical
  50. 4.9.1 Par Pharmaceutical Company Information
  51. 4.9.2 Par Pharmaceutical Business Overview
  52. 4.9.3 Par Pharmaceutical Skeletal Muscle Relaxants Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Par Pharmaceutical Skeletal Muscle Relaxants Product Portfolio
  54. 4.9.5 Par Pharmaceutical Recent Developments
  55. 4.10 Orient Pharma
  56. 4.10.1 Orient Pharma Company Information
  57. 4.10.2 Orient Pharma Business Overview
  58. 4.10.3 Orient Pharma Skeletal Muscle Relaxants Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Orient Pharma Skeletal Muscle Relaxants Product Portfolio
  60. 4.10.5 Orient Pharma Recent Developments
  61. 4.11 Ipsen
  62. 4.11.1 Ipsen Company Information
  63. 4.11.2 Ipsen Business Overview
  64. 4.11.3 Ipsen Skeletal Muscle Relaxants Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Ipsen Skeletal Muscle Relaxants Product Portfolio
  66. 4.11.5 Ipsen Recent Developments
  67. 4.12 Hikma Pharmaceuticals
  68. 4.12.1 Hikma Pharmaceuticals Company Information
  69. 4.12.2 Hikma Pharmaceuticals Business Overview
  70. 4.12.3 Hikma Pharmaceuticals Skeletal Muscle Relaxants Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Hikma Pharmaceuticals Skeletal Muscle Relaxants Product Portfolio
  72. 4.12.5 Hikma Pharmaceuticals Recent Developments
  73. 4.13 Aurobindo Pharma
  74. 4.13.1 Aurobindo Pharma Company Information
  75. 4.13.2 Aurobindo Pharma Business Overview
  76. 4.13.3 Aurobindo Pharma Skeletal Muscle Relaxants Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Aurobindo Pharma Skeletal Muscle Relaxants Product Portfolio
  78. 4.13.5 Aurobindo Pharma Recent Developments
  79. 4.14 Amneal Pharmaceuticals
  80. 4.14.1 Amneal Pharmaceuticals Company Information
  81. 4.14.2 Amneal Pharmaceuticals Business Overview
  82. 4.14.3 Amneal Pharmaceuticals Skeletal Muscle Relaxants Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Amneal Pharmaceuticals Skeletal Muscle Relaxants Product Portfolio
  84. 4.14.5 Amneal Pharmaceuticals Recent Developments
  85. 4.15 Accord Healthcare
  86. 4.15.1 Accord Healthcare Company Information
  87. 4.15.2 Accord Healthcare Business Overview
  88. 4.15.3 Accord Healthcare Skeletal Muscle Relaxants Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Accord Healthcare Skeletal Muscle Relaxants Product Portfolio
  90. 4.15.5 Accord Healthcare Recent Developments
5 Global Skeletal Muscle Relaxants Market Scenario by Region
  1. 5.1 Global Skeletal Muscle Relaxants Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Skeletal Muscle Relaxants Sales by Region: 2021-2032
  3. 5.2.1 Global Skeletal Muscle Relaxants Sales by Region: 2021-2026
  4. 5.2.2 Global Skeletal Muscle Relaxants Sales by Region: 2027-2032
  5. 5.3 Global Skeletal Muscle Relaxants Revenue by Region: 2021-2032
  6. 5.3.1 Global Skeletal Muscle Relaxants Revenue by Region: 2021-2026
  7. 5.3.2 Global Skeletal Muscle Relaxants Revenue by Region: 2027-2032
  8. 5.4 North America Skeletal Muscle Relaxants Market Facts & Figures by Country
  9. 5.4.1 North America Skeletal Muscle Relaxants Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Skeletal Muscle Relaxants Sales by Country (2021-2032)
  11. 5.4.3 North America Skeletal Muscle Relaxants Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Skeletal Muscle Relaxants Market Facts & Figures by Country
  16. 5.5.1 Europe Skeletal Muscle Relaxants Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Skeletal Muscle Relaxants Sales by Country (2021-2032)
  18. 5.5.3 Europe Skeletal Muscle Relaxants Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Skeletal Muscle Relaxants Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Skeletal Muscle Relaxants Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Skeletal Muscle Relaxants Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Skeletal Muscle Relaxants Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Skeletal Muscle Relaxants Market Facts & Figures by Country
  41. 5.7.1 South America Skeletal Muscle Relaxants Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Skeletal Muscle Relaxants Sales by Country (2021-2032)
  43. 5.7.3 South America Skeletal Muscle Relaxants Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Skeletal Muscle Relaxants Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Skeletal Muscle Relaxants Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Skeletal Muscle Relaxants Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Skeletal Muscle Relaxants Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Skeletal Muscle Relaxants Sales by Type (2021-2032)
  2. 6.1.1 Global Skeletal Muscle Relaxants Sales by Type (2021-2032) & (L)
  3. 6.1.2 Global Skeletal Muscle Relaxants Sales Market Share by Type (2021-2032)
  4. 6.2 Global Skeletal Muscle Relaxants Revenue by Type (2021-2032)
  5. 6.2.1 Global Skeletal Muscle Relaxants Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Skeletal Muscle Relaxants Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Skeletal Muscle Relaxants Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Skeletal Muscle Relaxants Sales by Application (2021-2032)
  2. 7.1.1 Global Skeletal Muscle Relaxants Sales by Application (2021-2032) & (L)
  3. 7.1.2 Global Skeletal Muscle Relaxants Sales Market Share by Application (2021-2032)
  4. 7.2 Global Skeletal Muscle Relaxants Revenue by Application (2021-2032)
  5. 7.2.1 Global Skeletal Muscle Relaxants Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Skeletal Muscle Relaxants Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Skeletal Muscle Relaxants Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Skeletal Muscle Relaxants Value Chain Analysis
  2. 8.1.1 Skeletal Muscle Relaxants Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Skeletal Muscle Relaxants Production Mode & Process
  5. 8.2 Skeletal Muscle Relaxants Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Skeletal Muscle Relaxants Distributors
  8. 8.2.3 Skeletal Muscle Relaxants Customers
9 Global Skeletal Muscle Relaxants Analyzing Market Dynamics
  1. 9.1 Skeletal Muscle Relaxants Industry Trends
  2. 9.2 Skeletal Muscle Relaxants Industry Drivers
  3. 9.3 Skeletal Muscle Relaxants Industry Opportunities and Challenges
  4. 9.4 Skeletal Muscle Relaxants Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst